UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Ramucirumab plus docetaxel versus placebo plus docetaxel for second-line treatment of stage IV non-small-cell lung cancer after disease progression on platinum-based therapy (REVEL): a multicentre, double-blind, randomised phase 3 trial

The Lancet (British edition), 2014-08, Vol.384 (9944), p.665-673

2014

Volltextzugriff (PDF)

Randomized Phase II Trial of Onartuzumab in Combination With Erlotinib in Patients With Advanced Non–Small-Cell Lung Cancer

Journal of clinical oncology, 2013-11, Vol.31 (32), p.4105-4114

2013

Volltextzugriff (PDF)

Capmatinib in MET Exon 14–Mutated or MET-Amplified Non–Small-Cell Lung Cancer

The New England journal of medicine, 2020-09, Vol.383 (10), p.944-957

2020

Volltextzugriff (PDF)

Coherent Anti-Stokes Raman Scattering Measurements of Time and Length Scales of Temperature Fluctuations in a Turbulent Flame

Applied spectroscopy, 2023-05, Vol.77 (5), p.482-490

2023

Volltextzugriff (PDF)

Electrochemical Sensors for Controlling Oxygen Content and Corrosion Processes in Lead-Bismuth Eutectic Coolant-State of the Art

Sensors (Basel, Switzerland), 2023-01, Vol.23 (2), p.812

2023

Volltextzugriff (PDF)

Phase III Study of Afatinib or Cisplatin Plus Pemetrexed in Patients With Metastatic Lung Adenocarcinoma With EGFR Mutations

Journal of clinical oncology, 2013-09, Vol.31 (27), p.3327-3334

2013

Volltextzugriff (PDF)

Adjuvant Erlotinib Versus Placebo in Patients With Stage IB-IIIA Non-Small-Cell Lung Cancer (RADIANT): A Randomized, Double-Blind, Phase III Trial

Journal of clinical oncology, 2015-12, Vol.33 (34), p.4007-4014

2015

Volltextzugriff (PDF)

Docetaxel plus nintedanib versus docetaxel plus placebo in patients with previously treated non-small-cell lung cancer (LUME-Lung 1): a phase 3, double-blind, randomised controlled trial

The lancet oncology, 2014-02, Vol.15 (2), p.143-155

2014

Volltextzugriff (PDF)

Investigation of changes regularities in the valence state during the formation of supported palladium-bismuth nanoparticles using XPS

New journal of chemistry, 2023-01, Vol.47 (2), p.719-724

2023

Volltextzugriff (PDF)

Afatinib versus cisplatin-based chemotherapy for EGFR mutation-positive lung adenocarcinoma (LUX-Lung 3 and LUX-Lung 6): analysis of overall survival data from two randomised, phase 3 trials

The lancet oncology, 2015-02, Vol.16 (2), p.141-151

2015

Volltextzugriff (PDF)

Inflammatory and autoimmune predictive markers of response to anti‑PD‑1/PD‑L1 therapy in NSCLC and melanoma

Experimental and therapeutic medicine, 2022-09, Vol.24 (3), Article 557

2022

Volltextzugriff (PDF)

Method for iodine radionuclides separation from primary coolant samples

Journal of radioanalytical and nuclear chemistry, 2023-06, Vol.332 (6), p.1767-1774

2023

Volltextzugriff (PDF)

Microcrystalline Luminescent (Eu1-xLnx)2bdc3·nH2O (Ln = La, Gd, Lu) Antenna MOFs: Effect of Dopant Content on Structure, Particle Morphology, and Luminescent Properties

Molecules (Basel, Switzerland), 2024-01, Vol.29 (2), p.532

2024

Volltextzugriff (PDF)

The Structure and Optical Properties of Luminescent Europium Terephthalate Antenna Metal-Organic Frameworks Doped by Yttrium, Gadolinium, and Lanthanum Ions

Molecules (Basel, Switzerland), 2024-07, Vol.29 (15), p.3558

2024

Volltextzugriff (PDF)

The location of the high- and low-affinity bilirubin-binding sites on serum albumin: Ligand-competition analysis investigated by circular dichroism

Biophysical chemistry, 2013-10, Vol.180-181, p.55-65

2013

Volltextzugriff (PDF)

Insulin Downregulates the Expression of ATP-binding Cassette Transporter A-I in Human Hepatoma Cell Line HepG2 in a FOXO1 and LXR Dependent Manner

Cell biochemistry and biophysics, 2023-03, Vol.81 (1), p.151-160

2023

Volltextzugriff (PDF)

Randomized Phase II Study of Erlotinib Plus Tivantinib Versus Erlotinib Plus Placebo in Previously Treated Non–Small-Cell Lung Cancer

Journal of clinical oncology, 2011-08, Vol.29 (24), p.3307-3315

2011

Volltextzugriff (PDF)

Randomized, Placebo-Controlled, Phase II Study of Veliparib in Combination with Carboplatin and Paclitaxel for Advanced/Metastatic Non-Small Cell Lung Cancer

Clinical cancer research, 2017-04, Vol.23 (8), p.1937-1944

2017

Volltextzugriff (PDF)

A global phase II randomized trial comparing oral taxane ModraDoc006/r to intravenous docetaxel in metastatic castration resistant prostate cancer

European journal of cancer (1990), 2024-05, Vol.202, p.114007-114007, Article 114007

2024

Volltextzugriff (PDF)

Application of Hierarchical Colored Petri Nets for Technological Facilities’ Maintenance Process Evaluation

Applied sciences, 2021-06, Vol.11 (11), p.5100

2021

Volltextzugriff (PDF)

Long‐term effects of crizotinib in ALK‐positive tumors (excluding NSCLC): A phase 1b open‐label study

American journal of hematology, 2018-05, Vol.93 (5), p.607-614

2018

Volltextzugriff (PDF)

Differentiation of human macrophages with anaphylatoxin C3a impairs alternative M2 polarization and decreases lipopolysaccharide‐induced cytokine secretion

Immunology and cell biology, 2022-03, Vol.100 (3), p.186-204

2022

Volltextzugriff (PDF)

Current status of molecular diagnostics for lung cancer

Exploration of targeted anti-tumor therapy, 2024-01, Vol.5 (3), p.742-765

2024

Volltextzugriff (PDF)

Treating non-small cell lung cancer with selumetinib: an up-to-date drug evaluation

Expert opinion on pharmacotherapy, 2020-11, Vol.21 (16), p.1943-1953

2020

Volltextzugriff (PDF)

1 – 25 von 657

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(487)
Mit Volltextzugriff
(488)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Englisch
(638)
Russisch
(32)
Japanisch
(3)

Erscheinungsjahr

n.n

Thema

Science & Technology
(275)
Life Sciences & Biomedicine
(144)
Physical Sciences
(99)
Humans
(90)
Technology
(88)
Chemistry
(58)
Oncology
(53)
Male
(49)
Female
(47)
Middle Aged
(42)
Physics
(42)
Aged
(39)
Adult
(34)
Lung Neoplasms - Drug Therapy
(34)
Biochemistry & Molecular Biology
(33)
Materials Science
(33)
Engineering
(30)
Physics, Applied
(30)
Carcinoma, Non-Small-Cell Lung - Drug Therapy
(29)
Materials Science, Multidisciplinary
(28)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(4)
... seit 90 Tagen
(14)

Menü

Weitere Dienste

Einstellungen

Ramucirumab plus docetaxel versus placebo plus docetaxel for second-line treatment of stage IV non-small-cell lung cancer after disease progression on platinum-based therapy (REVEL): a multicentre, double-blind, randomised phase 3 trial

Randomized Phase II Trial of Onartuzumab in Combination With Erlotinib in Patients With Advanced Non–Small-Cell Lung Cancer

Capmatinib in MET Exon 14–Mutated or MET-Amplified Non–Small-Cell Lung Cancer

Coherent Anti-Stokes Raman Scattering Measurements of Time and Length Scales of Temperature Fluctuations in a Turbulent Flame

Electrochemical Sensors for Controlling Oxygen Content and Corrosion Processes in Lead-Bismuth Eutectic Coolant-State of the Art

Phase III Study of Afatinib or Cisplatin Plus Pemetrexed in Patients With Metastatic Lung Adenocarcinoma With EGFR Mutations

Adjuvant Erlotinib Versus Placebo in Patients With Stage IB-IIIA Non-Small-Cell Lung Cancer (RADIANT): A Randomized, Double-Blind, Phase III Trial

Docetaxel plus nintedanib versus docetaxel plus placebo in patients with previously treated non-small-cell lung cancer (LUME-Lung 1): a phase 3, double-blind, randomised controlled trial

First-line ceritinib versus platinum-based chemotherapy in advanced ALK -rearranged non-small-cell lung cancer (ASCEND-4): a randomised, open-label, phase 3 study

Investigation of changes regularities in the valence state during the formation of supported palladium-bismuth nanoparticles using XPS

Afatinib versus cisplatin-based chemotherapy for EGFR mutation-positive lung adenocarcinoma (LUX-Lung 3 and LUX-Lung 6): analysis of overall survival data from two randomised, phase 3 trials

Inflammatory and autoimmune predictive markers of response to anti‑PD‑1/PD‑L1 therapy in NSCLC and melanoma

Method for iodine radionuclides separation from primary coolant samples

Microcrystalline Luminescent (Eu1-xLnx)2bdc3·nH2O (Ln = La, Gd, Lu) Antenna MOFs: Effect of Dopant Content on Structure, Particle Morphology, and Luminescent Properties

The Structure and Optical Properties of Luminescent Europium Terephthalate Antenna Metal-Organic Frameworks Doped by Yttrium, Gadolinium, and Lanthanum Ions

The location of the high- and low-affinity bilirubin-binding sites on serum albumin: Ligand-competition analysis investigated by circular dichroism

Insulin Downregulates the Expression of ATP-binding Cassette Transporter A-I in Human Hepatoma Cell Line HepG2 in a FOXO1 and LXR Dependent Manner

Randomized Phase II Study of Erlotinib Plus Tivantinib Versus Erlotinib Plus Placebo in Previously Treated Non–Small-Cell Lung Cancer

Randomized, Placebo-Controlled, Phase II Study of Veliparib in Combination with Carboplatin and Paclitaxel for Advanced/Metastatic Non-Small Cell Lung Cancer

A global phase II randomized trial comparing oral taxane ModraDoc006/r to intravenous docetaxel in metastatic castration resistant prostate cancer

Application of Hierarchical Colored Petri Nets for Technological Facilities’ Maintenance Process Evaluation

Long‐term effects of crizotinib in ALK‐positive tumors (excluding NSCLC): A phase 1b open‐label study

Differentiation of human macrophages with anaphylatoxin C3a impairs alternative M2 polarization and decreases lipopolysaccharide‐induced cytokine secretion

Current status of molecular diagnostics for lung cancer

Treating non-small cell lung cancer with selumetinib: an up-to-date drug evaluation

Suchergebnisse filtern